Pulmonary embolism - investigations

Investigating pulmonary embolism (PE) requires a multi-faceted approach, starting with clinical assessment and risk stratification using tools like the Wells or Geneva score. Diagnostic tests, including D-dimer, CTPA, V/Q scan, and echocardiography, are selected based on pre-test probability and patient-specific factors to confirm or exclude PE while minimizing risks such as radiation exposure and contrast-induced nephropathy.

Initial Assessment & Risk Stratification: The initial investigation of suspected pulmonary embolism (PE) begins with a thorough clinical assessment to determine pre-test probability. This assessment incorporates clinical prediction rules like the Wells score and the Geneva score, which evaluate factors such as signs and symptoms of DVT, heart rate, immobilization, prior PE/DVT, hemoptysis, and active malignancy. These scores categorize patients into low, intermediate, or high probability groups. Risk stratification is crucial because it influences the subsequent choice of diagnostic tests. For example, a low-probability patient may not require immediate imaging and could initially undergo a D-dimer test. A common misconception is that a normal ECG rules out PE; while ECG abnormalities are common in PE, a normal ECG does not exclude the diagnosis.

D-dimer Testing: D-dimer is a fibrin degradation product formed when cross-linked fibrin is broken down. Elevated D-dimer levels indicate that the coagulation cascade has been activated, suggesting the presence of a thrombus. D-dimer assays are highly sensitive but lack specificity for PE. This means that a negative D-dimer result in a low-probability patient effectively rules out PE, while a positive D-dimer requires further investigation. Conditions other than PE, such as infection, inflammation, malignancy, pregnancy, and recent surgery, can also elevate D-dimer levels, leading to false-positive results. Age-adjusted D-dimer thresholds are now often used, increasing the specificity in older patients by adjusting the cut-off value upwards. Using an age-adjusted threshold (age x 10 mcg/L in patients >50 years old) can significantly reduce the number of unnecessary CT pulmonary angiograms.

CT Pulmonary Angiography (CTPA): CTPA is the gold standard imaging modality for diagnosing PE. It involves injecting intravenous contrast and acquiring images of the pulmonary arteries during the arterial phase. CTPA allows for direct visualization of thrombi within the pulmonary vessels, confirming the diagnosis of PE. It also provides information about the location and extent of the embolism. While CTPA is highly accurate, it exposes patients to ionizing radiation and contrast dye, which can pose risks, especially in patients with renal insufficiency. The sensitivity and specificity of CTPA are generally high (over 90%), but can be affected by factors such as the size and location of the emboli, image quality, and reader experience. Subsegmental emboli detected on CTPA are sometimes of questionable clinical significance and can lead to overdiagnosis and unnecessary anticoagulation.

Ventilation/Perfusion (V/Q) Scan: A V/Q scan is an alternative imaging technique that assesses lung ventilation and perfusion. It involves inhaling a radioactive gas (ventilation) and injecting a radioactive tracer into the bloodstream (perfusion). Images are then acquired to compare ventilation and perfusion patterns. Mismatched defects (normal ventilation with reduced perfusion) suggest PE. V/Q scans are particularly useful in patients with contraindications to CTPA, such as renal insufficiency or contrast allergy. However, V/Q scans are less sensitive and specific than CTPA, and the results are often reported as low, intermediate, or high probability. Intermediate probability V/Q scans require further investigation. Furthermore, the interpretation of V/Q scans can be subjective and requires experienced radiologists.

Pulmonary Angiography: Pulmonary angiography, the original gold standard, is now rarely used for diagnosing PE due to the widespread availability of CTPA. It involves directly injecting contrast into the pulmonary arteries via a catheter and taking X-ray images. Pulmonary angiography is invasive and carries a higher risk of complications compared to CTPA. It is primarily reserved for situations where CTPA and V/Q scans are inconclusive, or when therapeutic intervention, such as thrombolysis or embolectomy, is being considered. Modern techniques have improved the safety of pulmonary angiography, but it still requires specialized expertise and is generally performed in tertiary care centers.

Echocardiography: Echocardiography, particularly transthoracic echocardiography (TTE), can provide valuable information in patients with suspected PE, especially in those who are hemodynamically unstable. While echocardiography cannot directly visualize pulmonary emboli, it can detect signs of right ventricular strain, such as right ventricular dilation, hypokinesis, and increased pulmonary artery pressure. McConnell's sign (right ventricular free wall hypokinesis with apical sparing) is a specific echocardiographic finding suggestive of PE. Echocardiography is non-invasive and can be performed rapidly at the bedside, making it a useful tool for risk stratification and guiding management in acute PE. A normal echocardiogram does not rule out PE, especially in patients with smaller emboli or chronic PE.

Lower Extremity Ultrasound: Since most pulmonary emboli originate from deep vein thrombosis (DVT) in the lower extremities, ultrasound of the legs is often performed in conjunction with other diagnostic tests for PE. A positive ultrasound demonstrating DVT supports the diagnosis of PE and may obviate the need for further imaging, particularly in patients with high clinical suspicion. However, a negative ultrasound does not rule out PE, as the source of the embolus may be in the pelvic veins or upper extremities. Furthermore, isolated calf vein thrombosis may not always be clinically significant and may not require anticoagulation. Serial ultrasound examinations may be performed to monitor for proximal extension of calf vein thrombi.

Arterial Blood Gas (ABG) Analysis: While not diagnostic for PE, arterial blood gas (ABG) analysis can provide supportive information. Common findings in PE include hypoxemia (low PaO2) and hypocapnia (low PaCO2) due to hyperventilation. However, ABG findings are variable and non-specific. Some patients with PE may have normal PaO2 levels, particularly those with smaller emboli or underlying lung disease. ABG analysis is useful for assessing the severity of respiratory compromise and guiding oxygen therapy but should not be used in isolation to diagnose or exclude PE.

Electrocardiogram (ECG): An ECG is a routine part of the initial evaluation for suspected PE. While there are no specific ECG findings that definitively diagnose PE, certain abnormalities are commonly observed, including sinus tachycardia, right axis deviation, right bundle branch block, and S1Q3T3 pattern (S wave in lead I, Q wave in lead III, and inverted T wave in lead III). These ECG changes reflect right ventricular strain and pulmonary hypertension. However, many patients with PE have a normal or non-specific ECG. The utility of ECG in PE diagnosis is primarily to assess for alternative diagnoses, such as acute myocardial infarction, which can mimic PE. It helps in risk stratification and provides a baseline for monitoring.

Pulmonary Embolism Rule-out Criteria (PERC Rule): The PERC rule is a clinical decision tool used to exclude PE in low-risk patients. It consists of eight criteria: age < 50 years, heart rate < 100 bpm, SaO2 > 94% on room air, no hemoptysis, no hormone use, no prior history of PE/DVT, no unilateral leg swelling, and no surgery/trauma requiring hospitalization within the previous 4 weeks. If all eight criteria are met, the probability of PE is very low, and further testing is generally not required. The PERC rule can help reduce the number of unnecessary D-dimer tests and CTPA scans, particularly in the emergency department setting. However, the PERC rule should only be applied in patients with low clinical suspicion for PE, as determined by clinical judgment or pre-test probability scores.

Integrating Investigations: The approach to investigating suspected PE involves integrating clinical assessment, pre-test probability scores, D-dimer testing, and imaging modalities. The choice of diagnostic tests should be individualized based on the patient's clinical presentation, risk factors, and contraindications. For example, a low-probability patient with a negative D-dimer does not require further testing, while a high-probability patient should undergo CTPA. V/Q scans are an alternative for patients with renal insufficiency or contrast allergy. Echocardiography and lower extremity ultrasound provide supportive information and aid in risk stratification. A multidisciplinary approach involving physicians, radiologists, and other healthcare professionals is essential for optimizing the diagnosis and management of PE.

Future Directions: Research continues to refine PE diagnostic strategies. Development of more specific D-dimer assays and improved imaging techniques, such as dual-energy CTPA, aims to enhance diagnostic accuracy and reduce radiation exposure. Artificial intelligence (AI) and machine learning (ML) are being explored to improve the interpretation of CTPA images and predict the risk of PE. Point-of-care D-dimer testing is becoming more widely available, allowing for rapid assessment of patients with suspected PE in outpatient settings. The ongoing focus is on developing personalized diagnostic algorithms that optimize the use of resources and improve patient outcomes.

Browse public study notes